ReShape Lifesciences
Price & Volume
Stats
See more52W Range | $0.30-$16.58 |
Market Cap | $3.8M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $8M |
Revenue Growth (YoY) | -8.9% |
Gross Profit (12 Mos) | $5M |
Diluted EPS | -$13.83 |
News
See moreYahoo Finance • 11 days ago
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
Yahoo Finance • 22 days ago
ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
Yahoo Finance • 24 days ago
ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
Yahoo Finance • last month
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders
About
CEO | Mr. Paul F. Hickey |
CFO | Mr. Thomas Stankovich |
Address | 18 Technology Drive, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 17 |
